Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2017-06-07

FDA Approved: NORVIR — Supplemental Application (AbbVie Inc.)

View source ↗

Summary

FDA approved a supplemental application for NORVIR (ritonavir) by AbbVie Inc.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Norvir (ritonavir)

Snippet

SUPPL AP for NORVIR (RITONAVIR)